Skip to main content


We're creating a new version of this page. See preview

  • Poster presentation
  • Open Access

Continuous electroencephalography in the surgical ICU

  • 1,
  • 2,
  • 1,
  • 1 and
  • 1
Critical Care201115 (Suppl 1) :P332

  • Published:


  • Liver Disease
  • Liver Transplant
  • Status Epilepticus
  • Organ Dysfunction
  • Severe Disability


The objective of this study is to investigate the prevalence, risk factors, and impact on outcome of electrographic seizures (ESz), nonconvulsive status epilepticus (NCSE), and periodic epileptiform discharges (PEDs) in surgical ICU (SICU) patients.


This was a retrospective study of 156 consecutive SICU patients (mean age 65 years old (IQR 54 to 74); 40% women) who underwent continuous electroencephalography (cEEG) monitoring for altered mental status. Poor outcome was defined as death or severe disability (Glasgow Outcome Score 4 or 5).


The majority of patients were admitted following abdominal surgery (36%) and post liver transplant (24%). Sepsis developed in 102 (65%) patients, almost all patients were mechanically ventilated (94%) and approximately one-half were comatose at the time of EEG monitoring (55%). Sixteen percent (n = 25) had ESz, 5% (n = 8) NCSE, and 29% (n = 45) had PEDs. All eight patients with NCSE were septic. Comatose patients and those with previous liver disease were more likely to have ESz or PEDs compared with noncomatose and those with normal liver function (42% vs. 19%; P = 0.002 and 25% vs. 9%; P = 0.007, respectively). After controlling for age, coma, and organ dysfunction, the presence of ESz was independently associated with death at hospital discharge (75% with vs. 43% without ESz; adjusted OR = 3.4 (95% CI = 1.04 to 10.9); P = 0.04).


In patients admitted to the SICU, ESz and PEDs are frequent and associated with poor outcome.

Authors’ Affiliations

Columbia University Medical Center, New York, USA
Casa de Saúde São José, Rio de Janeiro, Brazil


© Wahl et al. 2011

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.